**Procedure for receiving of sample **
^Name^Unique ID^ Edition/Date of Edition ^
|Procedure for receiving of sample |nchsls:c:Histopathology:document:10| 03-01-2015|

^Preparing authority^Approving authority^Review period^
|All teaching staff of Pathology Department |In-charge Histopathology|1 year|

|Controlled copy of this document exist in electronic form at IP address 10.207.3.240 of LAN at NCH, Surat|
|**Printed copy of this document with signature of authorized person is to be considered controlled. ** |


===1.Sample receiving policy:===
      -Patient Name
      -Patient ID
      -Department + Unit + Location
      -Date and time of Sample collection
      -Type of specimen
      -Clinical Diagnosis
  *Each indoor and outdoor patient of NCHS has unique MRD No.
  *It must be mentioned on both the request form and sample container.
  *In case of following Errors of positive identification of samples, concerned 
  *Clinician is contacted telephonically by sample receiver for correction of 
specimen /request form. 


  *Sample are processed after true positive of patient and sample.
  *Positive identification not mentioned on Sample container.
  *Positive identification not mentioned on Request Form.
  *Discrepancy in Positive identification between type of specimen and Request Form.

===2.Sample Rejection Policy:===
  *Histopathology Specimens are not rejected on the basis of poor specimen integrity. They are all accessioned & appropriate remarks are  incorporated in the gross, microscopic descriptions & diagnostic interpretation.
  *In the case of any discrepancy of specimen identification and traceability or specimen mislabeling, the specimen is not processed for examination till relevant information are obtained. Meanwhile concerned clinician is informed & necessary corrections are made. In the intervening  period ,the specimen is not discarded .

    
===3.Relevant Clinical information===
   *Mention following clinical information in request form:
        *Complete clinical history
        *Probable clinical diagnosis
        *Any relevant previous history
        *Any investigation done for the same(blood , radiological findings etc.)
        *Any treatment taken for the same
        *FNAC report if avilable
 





===4.Recording the identity of the person collecting the primary Sample===
   *The identity of the person collecting the primary sample must be mansion at the end of the request form along with contact number.


===5.Procedure for receiving surgical specimen===
  *Check the patient’s name, age, sex, MRD no, Ward & unit number & other important documentation details on Request form.
  *Check that it is the same on specimen also. 
  *Match properly the numbers of biopsy containers with the numbers written on forms.
  *With form mismatch details of specimen or autolysed specimen details telephonically informed to resident.
  *When the quality of the primary sample received is unsuitable for examination or could have compromised the result, this is indicated in the report.
  *Check for sufficient history of patient’s disease. 
  *Check for sufficient formalin & tissue preservation. 
  *After checking all these details, unique HP no. is given to each specimen which is entered in receiving register and also written on the specimen container.
  *HPE no. starts with 1 at the beginning of every year. Ex. H.P.No. 1/2020
  *All blocks and slides prepared from that specimen are also labelled with same HPE no. and multiple sections given from that specimen are labelled alphabetically in chronological order ex. A,B,C,D.The 
  *HPE reports of that are also prepared and dispatched on the same HPE number.
  *Remove sutures, clips & bone fragments.
  *Put sufficient numbers of cuts in large resected specimen such as uterus, ovary or mastectomy; put formalin soaked cotton in between slides of specimen as per standard guidelines.
  *After giving cuts, let the large specimen get fix for 24-48 hrs in 10% formalin solution.
  *Clean the knife & working platform, after giving sections from one pathological tissue to other tissue. This will prevent carryover of one pathological tissue to other tissue.